Skip to contentSkip to Braille Studio

Library / Laws / 118th Congress / House Bills / H.R. 456

H.R. 456

To amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.

Print stageDateSize⠃
Introduced in House2023-01-242.6K⠃⠗⠋